Biological perspectives: Incarcerated care and quetiapine abuse

Perspectives in Psychiatric Care

Volumn 44, Issue 3, 2008, Pages 202-206

  Keltner, Norman L ^a   Vance, David E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; QUETIAPINE;

ADDICTION; ADULT; CASE REPORT; DEINSTITUTIONALIZATION; FEAR; FEMALE; HEALTH SERVICE; HOSPITAL; HUMAN; MALINGERING; MENTAL DISEASE; MENTAL HOSPITAL; PRISONER; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC NURSING; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL ISOLATION; STATISTICS; TREATMENT REFUSAL;

ADULT; ANTIPSYCHOTIC AGENTS; DEINSTITUTIONALIZATION; DIAGNOSIS, DUAL (PSYCHIATRY); DIBENZOTHIAZEPINES; FEAR; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALS, PSYCHIATRIC; HOSPITALS, STATE; HUMANS; MALINGERING; MENTAL DISORDERS; PRISONERS; PSYCHIATRIC NURSING; SOCIAL ISOLATION; SUBSTANCE-RELATED DISORDERS; TREATMENT REFUSAL;

EID: 47249120450     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2008.00175.x     Document Type: Review

References (19)

1. Consumer Reports Best Buy Drugs (2006). Treating schizophrenia and bipolar disorder: The antipsychotics - Comparing effectiveness, safety, and price. Yonkers, NY: Consumer Reports Best Buy Drugs. Retrieved May 13, 2008, from http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/ AntipsychoticsFINAL.pdf?resultPageIndex=1&resultIndex=2
2. Fellner, J. Abramsky, S. (2003). Ill-equipped: U.S. prisons and offenders with mental illness. (Human Rights Watch report.) Retrieved February 5, 2008, from http://www.soros.org/initiatives/justice/articles_publications/ publications/ill_equipped_20031022
3. Green, B. (1999). Focus on quetiapine. Current Medical Research Opinion, 15, 145.
4. Hussain, M. Z., Waheed, W. Hussain, W. (2005). Intravenous quetiapine abuse. American Journal of Psychiatry, 162, 1755 1756.
5. Keltner, N. L. (2008). Biological Perspectives: Looking back at state hospitals: A biological advantage? Perspectives in Psychiatric Care, 44, 122 124.
6. Keltner, N. L. Folks, D. G. (2005). Psychotropic drugs (4th ed.). St. Louis, MO:Mosby.
7. Keltner, N. L., Schwecke, H. L. Bostrom, C. (2007). Psychiatric nursing (5th ed.). St. Louis, MO:Mosby.
8. Lieberman, J. A. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209 1223.
9. McConville, B. (2003). Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial. Journal of Child and Adolescent Psychopharmacology, 13, 75 82.
10. McManus, D. Q. (1999). Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders. Journal of Clinical Psychiatry, 60, 292.
11. Morin, A. K. (2007). Possible intranasal quetiapine misuse. American Society of Health-System Pharmacists, 64, 723 725.
12. Parsa, M. A. Bastani, B. (1998). Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease. Journal of Neuropsychiatry and Clinical Neuroscience, 10, 216.
13. Pierre, J. M., Shnayder, I., Wirshing, D. A. Wirshing, W. C. (2004). In tranasal quetiapine abuse. American Journal of Psychiatry, 161, 1718.
14. Pinta, E. R. Taylor, R. E. (2007). Quetiapine addiction? American Journal of Psychiatry, 164, 174 175.
15. Puffenberger, G. (2007). Pharmacy orientation (slide presentation for new pharmacists). MHM Services. (Used with permission.)
16. Quetiapine (Seroquel) abuse 2007). Pharmacist's Letter/Prescriber's Letter, 23 (10 231008.
17. Reeves, R. R. Brister, J. C. (2007). Additional evidence of the abuse potential of quetiapine. Southern Medical Journal, 100, 834 836.
18. Tarasoff, G. Osti, K. (2007). Black market value of antipsychotics, antidepressants, and hypnotics in Las Vegas, Nevada. American Journal of Psychiatry, 164, 358.
19. Waters, B. M. Joshi, K. G. (2007). Intravenous quetiapine-cocaine use ("Q ball"). American Journal of Psychiatry, 164, 173 174.